Mechanotransduction: How muscle contraction strengthens tendons

The force generated by muscles leads to signaling that helps to shape nearby tendon precursor cells.
  1. Nicole O Glenn  Is a corresponding author
  2. Clarissa A Henry  Is a corresponding author
  1. St. Jude Children's Research Hospital, United States
  2. University of Maine, United States

The Chinese classic text Tao Te Ching states that “A journey of a thousand miles begins with a single step”. However, this famous proverb does not consider the impact of these steps on the unsung heroes of the musculoskeletal system – the tendons that connect muscle to bones and enable the skeleton to move. Tendon injuries (such as tendonitis, tendinopathy, and tendon rupture) are painful and difficult to heal. Typically caused by overuse, and especially frequent in weightlifters, such injuries occur because the tendon does not adapt as readily to changes in tension as muscle does.

Tendons are fibrous extracellular matrices (ECMs) composed of collagen, proteoglycans and other glycoproteins. In mature tendons, these ECM proteins are secreted by tendon cells. One reason that tendon injuries heal slowly is that tendons have relatively few of these cells (Lui, 2015). Currently, there are no efficient therapies for tendon injuries because it is not well understood how tendons respond to muscle contractions. Now, in eLife, Thomas Schilling of the University of California, Irvine and colleagues – Arul Subramanian (UC Irvine) as first author, Lauren Kanzaki (UC Irvine), and Jenna Galloway (Massachusetts General Hospital) – demonstrate that developing zebrafish embryos are excellent models for studying how tendons adapt to forces (Subramanian et al., 2018). This is because zebrafish embryos have perfected the art of maintaining functional tendons during dramatic growth of the musculoskeletal system.

Muscles and tendons work as an integrated unit to transmit force to the skeletal system and stabilize joints, and there is clear evidence that they depend on each other to develop correctly. In mice, muscles and tendons develop during the same time period and the formation of tendon progenitor cells depends on the presence of early muscle in mouse embryos (Brent et al., 2005). In zebrafish, disrupting muscle development has detrimental effects on the structure of tendons, and disrupting the tendon results in abnormally long muscle fibers (Hall et al., 2007; Goody et al., 2010).

Little is known about how mechanical force affects tendon development, even though force plays an important role in tendon repair. Subramanian et al. therefore established a way to image how tendon precursor cells (also known as tenocytes) develop. This technique uses transgenic zebrafish in which the regulatory elements for a tenocyte-specific gene called scxa control when the fluorescent protein mCherry is expressed (Schweitzer et al., 2001; Chen and Galloway, 2014).

Subramanian et al. observed that muscle contraction helps to shape the tenocytes (Figure 1). The tenocytes elongate and extend protrusions perpendicular to the muscle cells. Unexpectedly, these protrusions are microtubule-based rather than the actin-based protrusions more frequently observed in cells.

Muscle contraction is required for normal tendon development.

(A) During normal muscle development, contractions increase the amount of extracellular matrix proteins, including collagen (green) and Thrombospondin (red), deposited in the developing tendon. These muscle contractions are also required for normal BMP signaling that prompts tenocytes (tendon precursor cells, blue) to elongate and extend complex protrusions (inset panels). (B) In the absence of muscle contraction, extracellular matrix deposition is decreased and tenocytes are rounded with shorter and less complex protrusions.

Immobilized zebrafish embryos developed misaligned tenocytes with shorter and less complex protrusions. The concentration of the tendon ECM protein Thrombospondin, which plays a critical role in tendon development and muscle maintenance (Subramanian and Schilling, 2014), was also disrupted. However, using electrical stimulation to induce muscle contraction in the immobilized zebrafish restored normal tenocyte development and tendon ECM. These creative experiments clearly demonstrate that contractile muscle tissue is required for tendon development.

How do cells integrate mechanical force with biochemical signals? This is a fundamental question throughout cell biology, and Subramanian et al. now have a hypothesis for how this works in tenocytes. They found that contractile force produced by muscle promotes the activity of a signaling pathway called TGFbeta in the tenocytes. Furthermore, TGFbeta is required to form the tenocyte protrusions and to express tenocyte-specific genes, including the gene that produces Thrombospondin. This suggests that one role of the tenocyte protrusions is to secrete and organize the tendon ECM.

The results reported by Subramanian et al. represent a dramatic step forward in our understanding of how tendons respond to contractile force during development. It remains to be seen whether similar mechanisms underlie muscle–tendon dynamics during tendon repair. Could electrical stimulation help tendons to repair themselves? Another major cause of tendon injury is the tendon ECM becoming less elastic with age, leaving one to wonder whether increasing Thrombospondin levels or activating TGFbeta signaling could rescue elasticity. If so, it is worth noting that the UC Irvine team had previously shown that the defects seen in Thrombospondin-deficient zebrafish can be rescued by expressing the human form of the protein (Subramanian and Schilling, 2014). This result indicates that zebrafish and human Thrombospondin work interchangeably, which will allow researchers to use the zebrafish model to investigate the therapeutic potential of this protein.

References

    1. Schweitzer R
    2. Chyung JH
    3. Murtaugh LC
    4. Brent AE
    5. Rosen V
    6. Olson EN
    7. Lassar A
    8. Tabin CJ
    (2001)
    Analysis of the tendon cell fate using scleraxis, a specific marker for tendons and ligaments
    Development 128:3855–3866.

Article and author information

Author details

  1. Nicole O Glenn

    Nicole O Glenn is in the Department of Hematology, St. Jude Children’s Research Hospital, Memphis, United States

    For correspondence
    nikkiollilaglenn@gmail.com
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8890-5506
  2. Clarissa A Henry

    Clarissa Henry is in the School of Biology and Ecology and the Graduate School for Biomedical Sciences and Engineering, University of Maine, Orono, United States

    For correspondence
    Clarissa.Henry@umit.maine.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7204-9231

Publication history

  1. Version of Record published: January 24, 2019 (version 1)

Copyright

© 2019, Glenn and Henry

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,394
    views
  • 243
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nicole O Glenn
  2. Clarissa A Henry
(2019)
Mechanotransduction: How muscle contraction strengthens tendons
eLife 8:e44149.
https://doi.org/10.7554/eLife.44149

Further reading

    1. Cell Biology
    Yuki Date, Yukiko Sasazawa ... Shinji Saiki
    Research Article

    The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including a-synuclein (aSyn) associated with the pathogenesis of Parkinson's disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1,200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble aSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.

    1. Cell Biology
    Zeina Salloum, Kristin Dauner ... Xiaohui Zha
    Research Article Updated

    Statins are known to be anti-inflammatory, but the mechanism remains poorly understood. Here, we show that macrophages, either treated with statin in vitro or from statin-treated mice, have reduced cholesterol levels and higher expression of Jmjd3, a H3K27me3 demethylase. We provide evidence that lowering cholesterol levels in macrophages suppresses the adenosine triphosphate (ATP) synthase in the inner mitochondrial membrane and changes the proton gradient in the mitochondria. This activates nuclear factor kappa-B (NF-κB) and Jmjd3 expression, which removes the repressive marker H3K27me3. Accordingly, the epigenome is altered by the cholesterol reduction. When subsequently challenged by the inflammatory stimulus lipopolysaccharide (M1), macrophages, either treated with statins in vitro or isolated from statin-fed mice, express lower levels proinflammatory cytokines than controls, while augmenting anti-inflammatory Il10 expression. On the other hand, when macrophages are alternatively activated by IL-4 (M2), statins promote the expression of Arg1, Ym1, and Mrc1. The enhanced expression is correlated with the statin-induced removal of H3K27me3 from these genes prior to activation. In addition, Jmjd3 and its demethylase activity are necessary for cholesterol to modulate both M1 and M2 activation. We conclude that upregulation of Jmjd3 is a key event for the anti-inflammatory function of statins on macrophages.